Treatment Options For Lung Cancer
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for [...]
Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. [...]
Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for [...]
Early Treatment with Lorlatinib Helps in Improving Lung Cancer Survival Rate
Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic [...]
Post-Surgical Lung Cancer Treatments
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. [...]
Health Benefits of Fennel for Lung Cancer Patients
Lung Cancer is a serious health problem having no respect for age and sex and can affect any person at any interval of time. Various ayurvedic herbs help lung [...]
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. [...]
Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating [...]
New Study Could Help in Personalizing Lung Cancer Treatment
Researchers at the University of Copenhagen have used highly sophisticated molecular analyzes for the purpose of identifying key proteins that signal pathways [...]
Researchers Link Genetic Mutations to Improved Outcomes in Lung Cancer Patients
Researchers have presented new findings related to lung cancer at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain. These new [...]
E-Sniffer to Predict Best Lung Cancer Treatment
The researchers have developed a novel device to distinguish between those who and will not respond to immunotherapy. They have reported in the Annals of [...]
Considering Unique Cancer Traits for Targeted Therapies
Lung cancer researchers Dr Kate Sutherland and Dr Sarah Best from the Walter and Eliza Hall Institute led the research and it has been published in Nature [...]